Sempra chief legal counsel Diana Day sells $304,029 in stock

Sempra Chief Legal Counsel Diana L. Day sold 3,300 shares on May 14, 2026 at $92.13 per share, totaling $304,029, under a pre-arranged Rule 10b5-1 plan. The filing also notes Sempra recently posted Q1 2026 adjusted EPS of $1.51, above the $1.49 consensus, but revenue of $3.66 billion missed the $4.1 billion estimate. The insider sale is routine and the earnings report was mixed, making the overall news largely neutral for shares.

Analysis

The only meaningful signal here is not the insider sale itself but the broader setup: SRE is screening like a bond proxy with equity-like valuation, which is a dangerous mix if rates stop falling or if utility growth fails to justify the multiple. A 31.5x earnings multiple leaves little room for execution slippage; in that regime, even a modest disappointment can compress the stock faster than fundamentals deteriorate. The fact that the sale was pre-planned limits bearish signaling, but it also means there is no incremental insider conviction offsetting the valuation risk.

The second-order effect is competitive capital allocation. If investors keep rewarding regulated/utilities-like names with AI-era scarcity multiples, capital may rotate toward “quality growth” balance sheets and away from lower-beta cash generators that lack a visible re-rating narrative. For SRE specifically, the post-earnings setup suggests the market is anchoring on EPS beats while discounting revenue/mix quality; that usually persists until a new catalyst forces a reset, which could be a rate shock, regulatory headwind, or capex surprise over the next 1-3 quarters.

Contrarian angle: the stock may still be a decent short even after a strong run because the base case is no longer about deterioration, it’s about multiple mean reversion. A 10-15% de-rating on unchanged earnings would erase a lot of the past year’s gain, and utilities often underperform quickly when investors rotate back into higher-duration growth like NVDA or APP. The AI-linked names are the real winners here—not operationally from this filing, but behaviorally, as capital may continue migrating from slow-growth defensives into names with structural scarcity and narrative momentum.

Key Decisions for Investors

• Short SRE outright or via put spreads into the next 4-8 weeks; target 10-15% downside from multiple compression, with risk capped if rates fall or a second consecutive quarter shows clean fundamental acceleration.
• Pair trade: short SRE / long NVDA on a 1-3 month horizon; the thesis is valuation compression in the utility while AI leadership maintains relative momentum, with the pair benefiting from a re-risking rotation.
• If holding SRE, trim into strength rather than waiting for confirmation; use a 5-7% trailing stop because the stock can re-rate lower quickly if the market shifts from EPS beats to revenue quality scrutiny.
• For more aggressive exposure, buy SRE puts six to nine months out around the next catalyst window; the setup is best for a slow grind lower rather than a single-event crash, so longer-dated optionality is more efficient than outright shorting.